Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

The Biotech Growth Trust (LSE:BIOG) Combines Buybacks With a Takeover-Heavy Biotech Portfolio

The Biotech Growth Trust, launched in June 1997, seeksCapitalappreciation throughInvestmentin the worldwide biotechnology industry. Its portfolio is managed by OrbiMed Advisors, with Geoffrey Hsu and Josh Golomb named as portfolio managers, while Frostrow Capital acts as alternative investmentFund Managerand company secretary. Performance is measured …

Divya Sood | 29 September 2026

HUTCHMED doses first patient in Phase Ia trial of HMPL-A830

On 28 September 2026 HUTCHMED (China) Limited (LSE:HCM) announced that it has started a global clinical trial of HMPL-A830 in patients with solid tumours. The first patient was dosed in China on 24 September 2026.

Ankur Sharma | 29 September 2026

Poolbeg Pharma doses 8 of about 30 patients in TOPICAL trial

On 28 September 2026 AIM-quoted Poolbeg Pharma plc (LSE:POLB) gave a recruitment update on TOPICAL, its clinical trial of POLB 001. The announcement said: "Following the previously announced six-patient safety cohort, a total of eight participants have now been dosed out of c.30, since …

Ankur Sharma | 29 September 2026

Surgical Innovations Group appoints Alex Warnock as CEO from 1 October

On 28 September 2026 AIM-quoted Surgical Innovations Group plc (LSE:SUN), which makes minimally invasive surgical products, announced a change of chief executive that takes effect on 1 October 2026. David Marsh is standing down as CEO and will stay on the board as a …

Ankur Sharma | 29 September 2026

Renalytix chair Julian Baines to step down at year-end

On 28 September 2026 Renalytix plc (LSE:RENX), a precision medicine diagnostics company focused on kidney disease, announced that its non-executive chair, Julian Baines MBE, intends to step down with effect from 31 December 2026.

Ankur Sharma | 29 September 2026

Why Did IXICO PLC LSE:IXI Rise 4.00% Amid a Firmer Tone Across London-Listed Neuroimaging Shares?

IXICO PLC — LSE:IXI closed 4.00% higher on29 September 2026, with the shares at 7.80p after a gain of 0.30p on the day.

Ishan Mudgal | 29 September 2026

Why Did Physiomics PLC LSE:PYC Rise 0.76% Amid a Firmer Tone Across London-Listed Biosciences Shares?

Physiomics PLC — LSE:PYC closed 0.76% higher on29 September 2026, with the shares at 0.529p after a gain of 0.004p on the day.

Ishan Mudgal | 29 September 2026

Why Did Provexis PLC LSE:PXS Fall 7.11% Amid a Softer Tone Across London-Listed Nutrition Science Shares?

Provexis PLC — LSE:PXS closed 7.11% lower on29 September 2026, with the shares at 0.836p after a decline of 0.064p on the day.

Ishan Mudgal | 29 September 2026

Why Did TruSpine Technologies PLC LSE:TRUE Rise 1.11% Amid a Firmer Tone Across London-Listed Medical Device Shares?

TruSpine Technologies PLC — LSE:TRUE closed 1.11% higher on29 September 2026, with the shares at 3.10p after a gain of 0.03p on the day.

Ishan Mudgal | 29 September 2026

How International Biotechnology Trust (LSE:IBT) Benefited From a Run of Biotech Takeovers in Its Portfolio

International Biotechnology Trust PLC is a London-listedInvestmenttrust that invests in biotechnology and related companies. Its portfolio managers are Ailsa Craig and Marek Poszepczynski, with Schroder Investment Management Limited acting as alternative investmentFund Managerand company secretary. The trust also holds interests inVenture Capitalfunds managed by …

Ankur Sharma | 29 September 2026
Support

Hi! How can we help you today?

Loading…